Investors

Investors

Summary: De.mem (ASX: DEM)

De.mem started operations in 2014 with the vision to become the leading provider for de-centralized, membrane-based solutions for industrial and domestic water treatment. In the meantime, the company has grown to about 75 employees with offices in Brisbane, Perth, Kalgoorlie, Launceston, Melbourne, Wodonga (Australia), Singapore, and Velbert (Germany).

De.mem offers a range of Singapore-made hollow fibre membranes, often deployed as the key component of its products. This includes innovations such as the company’s graphene-oxide enhanced polymer membrane.

Key milestones in the development of De.mem are as follows:

  • 2015    Completed a number of municipal / residential projects in Vietnam
  • 2016    Signed lighthouse industrial waste water BOO contracts with multinational corporations in Singapore
  • 2017    Listed on the Australian Stock Exchange
    Started factory for the production of hollow fibre membranes in Singapore
    Signed contracts with leading players from the Australian mining sector
  • 2018    1.7 million A$ award for waste water treatment plant in South Australia
  • 2019    2.8 million A$ award for seawater desalination plant in Queensland
    1.7 million A$ Build, Own, Operate contract for industrial waste water treatment in Singapore
    Acquired Pumptech Tasmania Pty Ltd (now: De.mem-Pumptech) and Geutec GmbH, Essen, Germany (now: De.mem-Geutec)
  • 2020    2.7 million A$ contract for supply of a seawater desalination plant
  • 2021    Acquired Capic in Perth, Western Australia (now: De.mem-Capic)
  • 2022   Acquired Stevco in Epping/Melbourne, Victoria (now: De.mem-Stevco)
  • 2024   Received American NSF certification for Graphene Oxide enhanced membrane
    Acquired Auswater Systems Pty Ltd and Border Pumpworks
  • 2025   Acquired Core Chemicals Pty Ltd, Perth, Western Australia

Why Invest in De.mem ?

  • Strong ESG (Environmental, Social, Governance) impact
  • Large addressable market – the global water and waste water solutions market has an estimated annual capital expenditure of $AUD 240 billion (source: Frost & Sullivan)
  • Offering breakthrough technological innovations developed in-house and at Nanyang Technological University (NTU) in Singapore – ranked among the leading research institutions in membrane science worldwide
  • Track record of 27 successive quarters of growth vs. pcp (Dec 2025)
  • Stable, high-margin business model around the supply of services, equipment, chemicals, pumps and consumables
  • Well established blue chip customer base from high growth industrial sectors
  • Track record of well-integrated, bolt-on acquisitions

Share Registry

MUFG Corporate Markets
Locked Bag A14, Sydney South NSW 1235

Telephone: 1300 554 474
Outside of Australia: +61 1300 554 474
Fax: 02 9287 0303

Click here to view and update your

security holder information.
link

Share Price
Chart

Financial Calendar

Next AGM: May 2026

March Quarterly: end April 2026

H1 Report 2026: August 2026

Investor Presentation

Click here
link Investor Presentation

Stay up to date

Sign Up For Our Mailing List

De.mem ASX ANNOUNCEMENTS

  • Corporate Governance Statement

    03/03/2026

  • Investor Presentation

    28/02/2026

  • CY 2025 Financial Results

    28/02/2026